Cargando…

Nasopharyngeal cancer cell‐derived exosomal PD‐L1 inhibits CD8+ T‐cell activity and promotes immune escape

Programmed cell death ligand 1 (PD‐L1) is an immune surface protein that binds to programmed cell death 1 (PD‐1) and allows tumors to evade T‐cell immunity. This study aims to define the role of PD‐L1 shuttled by tumor cell‐derived exosomes in the immune escape of nasopharyngeal carcinoma (NPC). PD‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jie, Chen, Jierong, Liang, Hu, Yu, Yahui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459270/ https://www.ncbi.nlm.nih.gov/pubmed/35598173 http://dx.doi.org/10.1111/cas.15433

Ejemplares similares

PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8(+) T Cell Killing
por: Akhmetzyanova, Ilseyar, et al.
Publicado: (2015)

Correction: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
por: Akhmetzyanova, Ilseyar, et al.
Publicado: (2015)

Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
por: Zhou, Kaijian, et al.
Publicado: (2020)

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
por: Kim, Dong Ha, et al.
Publicado: (2019)

Construction of Exosomes that Overexpress CD47 and Evaluation of Their Immune Escape
por: Ben, Xin-Yu, et al.
Publicado: (2022)

Prostate cancer cells synergistically defend against CD8 (+) T cells by secreting exosomal PD‐L1
por: Li, Dameng, et al.
Publicado: (2023)

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017)

Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma
por: Gao, Qian, et al.
Publicado: (2021)

Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
por: Hu, Zongqiang, et al.
Publicado: (2023)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

PPARγ inhibited tumor immune escape by inducing PD‐L1 autophagic degradation
por: Gou, Qian, et al.
Publicado: (2023)

Tumor-derived exosomes induce CD8(+) T cell suppressors
por: Maybruck, Brian T., et al.
Publicado: (2017)

HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
por: Han, Qiuju, et al.
Publicado: (2019)

Semen-Derived Exosomes Mediate Immune Escape and Transmission of Reticuloendotheliosis Virus
por: Su, Qi, et al.
Publicado: (2021)

Single‐cell analysis reveals the multiple patterns of immune escape in the nasopharyngeal carcinoma microenvironment
por: Lin, Qianyu, et al.
Publicado: (2023)

PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
por: Cretella, Daniele, et al.
Publicado: (2019)

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion
por: Fang, Wenli, et al.
Publicado: (2021)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
por: Ge, Junshang, et al.
Publicado: (2021)

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
por: Qiu, Yufan, et al.
Publicado: (2021)

Tumor derived exosome induction of the CD3+CD8+ T cell tolerogenic phenotype
por: Maybruck, Brian, et al.
Publicado: (2013)

Correction to: Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion
por: Fang, Wenli, et al.
Publicado: (2022)

The Effect of Interference on the CD8(+) T Cell Escape Rates in HIV
por: Garcia, Victor, et al.
Publicado: (2015)

CD80 Expressed by CD8(+) T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8(+) T Cells
por: Rollins, Meagan R., et al.
Publicado: (2017)

Mutational escape from CD8(+) T cell immunity: HCV evolution, from chimpanzees to man
por: Bowen, David G., et al.
Publicado: (2005)

Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
por: Niogret, Julie, et al.
Publicado: (2021)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2021)

BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non–small cell lung cancer
por: Liu, Junwei, et al.
Publicado: (2023)

Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma
por: Ludwig, Nils, et al.
Publicado: (2020)

Tumor-draining lymph node-derived tumor-specific memory CD8(+) T cells: a key player in PD-1/PD-L1 immunotherapy
por: Yin, Enzhi, et al.
Publicado: (2023)

LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination via MiR-30a-5p/USP22
por: Xian, Di, et al.
Publicado: (2021)

Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8(+) T Cells co-expressing PD-1 and LAG-3 inhibitory receptors
por: Mishra, Ameet K., et al.
Publicado: (2016)

TGF-β1-Mediated PD-L1 Glycosylation Contributes to Immune Escape via c-Jun/STT3A Pathway in Nasopharyngeal Carcinoma
por: Ma, Xue-Min, et al.
Publicado: (2022)

GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages
por: Chen, Jinhong, et al.
Publicado: (2021)

Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
por: Vautrot, Valentin, et al.
Publicado: (2021)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8(+) T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2023)

Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1− Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy
por: Miracco, Clelia, et al.
Publicado: (2021)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k6s21235csoatokuqgmov404al